UK Companies House feature
PENLON LIMITED
Cash
£2M
+88.3% vs 2023
Net assets
£7M
+11.7% vs 2023
Employees
119
-9.2% vs 2023
Profit before tax
£1M
-26.5% vs 2023
Profile
- Company number
- 03228364
- Status
- Active
- Incorporation
- 1996-07-23
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 32500
- Hubs
- UK Healthcare
Profit before tax
3-year trend · vs UK Healthcare median
Accounts
3-year trend · latest 2024-12-31
| Metric | Trend | 2023-03-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Turnover | — | — | — | |
| Operating profit | — | — | — | |
| Profit before tax | -£3,026,457 | £1,426,152 | £1,048,276 | |
| Net profit | -£3,004,955 | £1,625,998 | £765,877 | |
| Cash | £1,634,020 | £1,036,318 | £1,950,886 | |
| Total assets less current liabilities | £4,944,890 | £6,570,888 | £7,336,765 | |
| Net assets | — | — | — | |
| Equity | £4,944,890 | £6,570,888 | £7,336,765 | |
| Average employees | 120 | 131 | 119 | |
| Wages | £4,766,064 | £3,888,819 | £4,883,479 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Gravita Audit Oxford LLP
- Audit opinion
- Qualified
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “The company introduced the new product line, endoscopy, in 2024, which is a different business for Penlon. It had its first complete year in 2024 with breakthrough in key hospital accounts and submission of the Endoscopy framework.”
- “The new ERP system implemented a year ago improved data transparency and decision-making.”
- “Cost reduction will be a key target in 2025 due to complexity of material verification in 2024.”
- “Management aims to strengthen the new endoscopy business and secure R&D for next-generation anaesthesia machines.”
- “The Company continues to invest in research and development activities and is working with the Medcaptain R&D team to develop next-generation products and optimize its current product range.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
5 active · 27 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GAO, Xiaoming | Director | 2022-01-19 | Sep 1983 | Chinese |
| LIU, Jie | Director | 2022-01-19 | Nov 1968 | Canadian |
| MOSS, Linda Jane | Director | 2019-04-29 | Dec 1966 | British |
| XIAO, Tianshi | Director | 2022-10-28 | Jun 1969 | Chinese |
| ZHONG, Yaoqi | Director | 2022-01-19 | Dec 1976 | Chinese |
Show 27 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FRANKLIN, Stuart Kenneth | Secretary | 2012-06-15 | 2019-04-15 |
| HARWOOD SMITH, Richard Martin | Secretary | 2007-04-30 | 2012-06-15 |
| RAE, John Lawrence | Secretary | 2002-12-18 | 2003-05-27 |
| A B & C SECRETARIAL LIMITED | Corporate Nominee Secretary | 1996-07-23 | 2002-12-18 |
| COBBETTS (SECRETARIAL) LIMITED | Corporate Secretary | 2003-05-27 | 2007-04-30 |
| ARMSTRONG, Simon John | Director | 2004-12-16 | 2008-12-15 |
| FRANKLIN, Stuart Kenneth | Director | 2014-02-24 | 2019-04-15 |
| GIL-RODRIGUEZ, Ian Edward | Director | 2009-06-22 | 2011-08-16 |
| GUPTA, Aditya | Director | 2015-08-21 | 2019-06-27 |
| HARWOOD SMITH, Richard Martin | Director | 2005-06-07 | 2012-06-30 |
| JINDAL, Ajay | Director | 2015-08-21 | 2022-01-19 |
| KELLY, Maxwell | Director | 2007-06-14 | 2011-08-12 |
| KHURANA, Sunil Kumar | Director | 2015-08-21 | 2022-01-19 |
| KRISHNAMOORTHY, Guruswamy | Director | 2019-04-29 | 2022-10-28 |
| LEYLAND, Peter Anthony | Director | 2009-08-18 | 2011-03-31 |
| MACMILLAN, Anne Elizabeth | Director | 2009-12-23 | 2012-07-27 |
| MOON, Stephen Edward | Director | 2011-04-01 | 2016-01-21 |
| NAGPAL, Praveen Kumar | Director | 2019-06-27 | 2022-01-19 |
| NANDA, Harsh | Director | 2015-08-21 | 2020-03-07 |
| PRICE, William Frederick Ernest | Director | 1996-11-14 | 2000-06-01 |
| RAE, John Lawrence | Director | 1996-09-30 | 2005-06-07 |
| TUDOR, Peter Hugh | Director | 1996-09-10 | 2004-10-18 |
| WALSH, Julia Maria, Dr | Director | 2000-06-01 | 2002-12-18 |
| WATKINS, Andrew Bryan | Director | 2007-06-14 | 2009-10-31 |
| WOND, Geoffrey Ian | Director | 1996-09-30 | 1998-09-28 |
| WORRALLO, Peter Anthony | Director | 2005-09-12 | 2023-06-30 |
| INHOCO FORMATIONS LIMITED | Corporate Nominee Director | 1996-07-23 | 1996-09-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Intermed Ltd | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 224 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-09-30 | AA | accounts | accounts with accounts type full |
| 2025-07-25 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-06-27 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-12-03 | AA | accounts | accounts with accounts type full |
| 2024-08-06 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-08-06 | CH01 | officers | change person director company with change date |
| 2024-08-06 | CH01 | officers | change person director company with change date |
| 2024-08-06 | CH01 | officers | change person director company with change date |
| 2024-05-22 | CH01 | officers | change person director company with change date |
| 2024-05-22 | CH01 | officers | change person director company with change date |
| 2024-04-13 | AA | accounts | accounts with accounts type full |
| 2023-11-13 | AA01 | accounts | change account reference date company current shortened |
| 2023-10-30 | CH01 | officers | change person director company with change date |
| 2023-07-27 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-07-27 | TM01 | officers | termination director company with name termination date |
| 2023-06-05 | CH01 | officers | change person director company with change date |
| 2023-06-05 | CH01 | officers | change person director company with change date |
| 2023-04-12 | AA | accounts | accounts with accounts type full |
| 2022-11-07 | AP01 | officers | appoint person director company with name date |
| 2022-11-07 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory